EffCaMgCit

· University of Texas Southwestern Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EffCaMgCit, covering 2025-05-23 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy [Phase 3]